NeoGenomics Inc. | Key People and Executives
Douglas M. Van Oort
Executive Chairman & Chief Executive Officer
Steven C. Jones
Director & Executive Vice President
Stephen Kanovsky
Independent Director
Raymond R. Hipp
Independent Director
Kevin C. Johnson
Independent Director
Bruce K. Crowther
Independent Director
Alison L. Hannah
Independent Director
Lynn A. Tetrault
Independent Director
Douglas M. Van Oort
Executive Chairman & Chief Executive Officer
Steven G. Brodie
Chief Scientific Officer & VP-Operations
Sharon A. Virag
Chief Financial Officer
Steven A. Ross
Chief Information Officer & Vice President
Maher Albitar
Chief Medical Officer & Senor Vice President
Gina Wallar
Division VP-Pharma Services National Sales
Jennifer Balliet
Vice President & Chief Culture Officer
Stephanie Bywater
Chief Compliance Officer
George A. Cardoza
President-Pharma Services Division
Robert J. Shovlin
Chief Growth Officer & President-Clinical Services
Alan Cotton
Vice President-BioPharma & Business Development
Steven C. Jones
Director & Executive Vice President
William Bishop Bonello
Treasurer, VP-Strategy & Corporate Development
Kathryn McKenzie
Chief Accounting Officer & Vice President-Finance
Denise E. Pedulla
Secretary & General Counsel
Stephen Kanovsky
Independent Director
Raymond R. Hipp
Independent Director
Kevin C. Johnson
Independent Director
Bruce K. Crowther
Independent Director
Alison L. Hannah
Independent Director
Lynn A. Tetrault
Independent Director
| Address |
12701 Commonwealth Drive
Fort Myers Florida 33913
United States
|
|
Employees
|
- |
| Website |
http://www.neogenomics.com |
| Updated |
07/08/2019 |
| NeoGenomics, Inc. provides cancer diagnostics and pharma services. It operates through a network of cancer focused testing laboratories to provide genetic and molecular testing services. It offers various testing services, including Cytogenetics, Fluorescence In-Situ Hybridization, Flow Cytometry, Immunohistochemistry, Molecular testing and Pathology consultation. |
